No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
SGRY240816C30000
- 1.90
- -0.30-13.64%
15min DelayClose Jul 19 15:57 ET
2.70High1.90Low
2.30Open2.20Pre Close3 Volume403 Open Interest30.00Strike Price690.00Turnover77.36%IV9.81%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry1.90Extrinsic Value100Contract SizeAmericanOptions Type0.4861Delta0.0665Gamma14.35Leverage Ratio-0.0482Theta0.0086Rho6.97Eff Leverage0.0309Vega
Intraday
- 5D
- Daily
News
Surgery Partners (SGRY) Poised for Upside: A Comprehensive Buy Rating Justification
Riot Platforms & North Face Parent V.F. Corp Are Among 11 Mid-Cap Stocks That Performed The Best Last Week (July 14-July 20): Are Others In Your Portfolio?
These eleven mid-cap stocks were the best performers in the last week. Are they in your portfolio?Virtu Financial, Inc. (NASDAQ:VIRT) shares jumped 30.04% after reporting better-than-expected Q2
Sector Update: Health Care Stocks Rise Friday Afternoon
Health care stocks were advancing Friday afternoon, with the NYSE Health Care Index adding 0.4% and the Health Care Select Sector SPDR Fund (XLV) up 0.5%.The iShares Biotechnology ETF (IBB) shed 0.2%.
Market Chatter: Surgery Partners Exploring Potential Sale
Surgery Partners (SGRY) is considering strategic options, including a potential sale, and is working with a financial adviser to evaluate buyer interest, Bloomberg reported late Thursday, citing
Surgery Partners (NASDAQ:SGRY) Shareholder Returns Have Been Incredible, Earning 300% in 5 Years
Express News | Surgery Partners Shares Are Trading Higher Following a Report Suggesting the Company Is Exploring Sale Options
Comments
Surgery Partners' historical ROCE trend doesn't indicate potential for future multi-bagger status. Persistent low return on capital from its investments makes it unlikely to be a multi-bagger.
Returns On Capital At Surgery Partners (NASDAQ:SGRY) Have Hit The Brakes 1
Surgery Partners' high P/S ratio, despite industry-standard revenue forecasts, could risk shareholders' investments and potential investors may pay an unnecessary premium. This may be due to bullish sentiment, which could lead to disappointment if the P/S falls in line with the growth outlook.
Given Surgery Partners' current ROCE trends, it is not seen as a potential high-yield investment. Despite the stock's impressive performance in past years, if current underlying trends continue, the odds of it being a multi-bagger from here is slim.
Upgrades
• $Arcos Dorados(ARCO.US$ : Bradesco BBI Upgrades to Outperform from Neutral - PT $12
• $Armstrong World Industries(AWI.US$ : Loop Capital Upgrades to Buy from Hold - PT $95
• $Cullen/Frost Bankers(CFR.US$ : JPMorgan Upgrades to Overweight from Underweight - PT $155 (from $143)
• $Digital Realty Trust Inc(DLR.US$ : Deutsche Bank Upgrades to Buy from Hold - PT $144 (from $150)
• $Liberty Formula One-A(FWONA.US$ : Mor...
• $Arcos Dorados(ARCO.US$ : Bradesco BBI Upgrades to Outperform from Neutral - PT $12
• $Armstrong World Industries(AWI.US$ : Loop Capital Upgrades to Buy from Hold - PT $95
• $Cullen/Frost Bankers(CFR.US$ : JPMorgan Upgrades to Overweight from Underweight - PT $155 (from $143)
• $Digital Realty Trust Inc(DLR.US$ : Deutsche Bank Upgrades to Buy from Hold - PT $144 (from $150)
• $Liberty Formula One-A(FWONA.US$ : Mor...
12
Read more